Bright Minds Biosciences (DRUG) Insider Trading & Ownership $28.27 +0.39 (+1.40%) Closing price 04:00 PM EasternExtended Trading$28.41 +0.14 (+0.49%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bright Minds Biosciences (NASDAQ:DRUG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.66%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.06MNumber OfInsiders Selling(Last 12 Months)0 Get DRUG Insider Trade Alerts Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DRUG Insider Buying and Selling by Quarter Bright Minds Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/15/2024Cormorant Asset Management, LpMajor ShareholderBuy372,591$5.53$2,060,428.23 (Data available from 1/1/2013 forward) DRUG Insider Trading Activity - Frequently Asked Questions Who is on Bright Minds Biosciences's Insider Roster? The list of insiders at Bright Minds Biosciences includes Cormorant Asset Management, Lp. Learn more on insiders at DRUG. What percentage of Bright Minds Biosciences stock is owned by insiders? 42.66% of Bright Minds Biosciences stock is owned by insiders. Learn more on DRUG's insider holdings. Which Bright Minds Biosciences insiders have been buying company stock? The following insider purchased DRUG shares in the last 24 months: Cormorant Asset Management, Lp ($2,060,428.23). How much insider buying is happening at Bright Minds Biosciences? Insiders have purchased a total of 372,591 DRUG shares in the last 24 months for a total of $2,060,428.23 bought. Bright Minds Biosciences Key ExecutivesMr. Ian McDonald (Age 35)Co-Founder, CEO, President & Director Mr. Ryan E. S. K. Cheung B.Com. (Age 46)CA, CPA, Chief Financial Officer Compensation: $89.23kDr. Jan Torleif Pedersen M.Sc. (Age 59)Ph.D., Chief Science Officer & Director Compensation: $181.09kDr. Mark A. Smith M.D. (Age 69)Ph.D., Chief Medical Officer Compensation: $243.54kMr. Alex VasilkevichCOO & VP of Corporate DevelopmentDr. Emer Leahy M.B.A. (Age 57)Ph.D., Consultant More Insider Trading Tools from MarketBeat Related Companies Replimune Group Insider Buying Cronos Group Insider Buying Vir Biotechnology Insider Buying AbCellera Biologics Insider Buying Iovance Biotherapeutics Insider Buying KalVista Pharmaceuticals Insider Buying Day One Biopharmaceuticals Insider Buying ORIC Pharmaceuticals Insider Buying Xeris Biopharma Insider Buying AnaptysBio Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite Disparity This page (NASDAQ:DRUG) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
